The Indian Council of Medical Research (ICMR), the leading authority for biomedical research in India, has issued an Expression of Interest (EoI) for organizations, companies, and manufacturers to develop and produce a lateral flow-based point-of-care device for serum ferritin quantification.
The initiative is aimed at enhancing early diagnosis and treatment of iron deficiency and anemia in India.
Importance of Serum Ferritin in Health Diagnosis
Serum ferritin serves as a key biomarker for iron status in the body, playing a crucial role in diagnosing conditions such as iron deficiency and anemia.
The development of an accessible and effective point-of-care device for serum ferritin quantification will significantly improve healthcare outcomes, enabling timely interventions for millions affected by anemia.
Collaboration with Cornell University
ICMR is collaborating with Cornell University to bring this innovation to India. A central aspect of this partnership is adapting Cornell’s AnemiaPhone technology for non-commercial use, supporting the Government’s Anaemia Mukt Bharat mission.
Under the collaboration, Cornell University will share vital technical data, designs, schematics, and documentation with ICMR to facilitate the device’s development and mass production.
Call for Competent Companies to Partner with ICMR
ICMR is seeking collaboration with competent organizations to develop and manufacture the serum ferritin quantification device based on AnemiaPhone technology.
The selected company will be responsible for independent validation of the device once developed, as well as for large-scale manufacturing following necessary approvals.
ICMR’s Role in the Initiative
ICMR, together with Cornell University, will provide technical oversight and expert guidance throughout the project.
The council will assist in validation according to the terms of the agreement and offer support without bearing direct financial obligations.
Expectations from Partnering Companies
The chosen company will need to ensure the necessary infrastructure, materials, and workforce to develop the device.
It will also be required to share technical data with ICMR and Cornell University and allow authorized personnel to inspect their labs and production facilities.
Deadline and Submission Details
The last date for submitting the Expression of Interest is February 28, 2025. Interested parties are encouraged to apply before the deadline.
Public Health Impact and Strategic Alignment
The initiative aligns with India’s public health priorities, especially in addressing anemia, a condition affecting millions across the country. By enabling early diagnosis of iron deficiency anemia, this device will help improve health outcomes and support the Government’s ongoing efforts to combat anemia.
Disclaimer
As reported by pharmabiz.com, ICMR reserves the right to cancel the EoI at any time, amend the details, or add new terms as necessary, without any obligation to the applicants.